PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-31.01%
Negative net income growth while BTE stands at 315.24%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-23.63%
Negative yoy D&A while BTE is 11434.78%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-26.56%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
253.33%
SBC growth well above BTE's 65.30%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-35.14%
Both reduce yoy usage, with BTE at -4.46%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-34.13%
AR is negative yoy while BTE is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
19.05%
Inventory growth of 19.05% while BTE is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
44.37%
AP growth of 44.37% while BTE is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-35.14%
Both reduce yoy usage, with BTE at -4.46%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
124.07%
Some yoy increase while BTE is negative at -99.16%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-22.19%
Negative yoy CFO while BTE is 3.99%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-4.92%
Negative yoy CapEx while BTE is 26.98%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-1249.20%
Both yoy lines negative, with BTE at -282048.51%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
334.85%
We have some outflow growth while BTE is negative at -44.07%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-248.55%
Both yoy lines negative, with BTE at -294.87%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
98.59%
We repay more while BTE is negative at -2804.68%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
62.76%
Buyback growth at 50-75% of BTE's 100.00%. Martin Whitman questions partial disadvantage in per-share enhancements if competitor repurchases more.